the role of immunotherapy in endocrine-refractory luminal breast cancer
Published 2 years ago • 165 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:34
future role of immunotherapy in her2 breast cancer
-
2:05
immunotherapy in breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
1:23
exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
-
0:38
the role of the oncotype dx assay in the management of patients with breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
1:43
the role of the checkpoint inhibitors in breast cancer
-
3:50
the role of soft and text in treatment decision making for patients with breast cancer
-
2:34
the role of immunotherapy in breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:30
the role of myeloid-derived suppressor cells in breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
3:26
chemo-immunotherapy for tnbc
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
1:12
the adapting role of the cancer nurse: immunotherapy
-
1:28
the evolution of immunotherapy for breast cancer